Top Markets
Coin of the day
Yew Bio-Pharm Group, Inc. Yew Bio-Pharm Group, Inc.

Yew Bio-Pharm Group, Inc.

YEWB
Rank in Stocks #41774
Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew... Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew trees across both the People's Republic of China and the United States, utilizing its subsidiaries. A significant portion of its operations involves supplying raw yew materials, specifically branches and leaves, for the production of Traditional Chinese Medicine (TCM), particularly those containing the compound taxol. The company also processes and distributes these vital yew components for TCM applications. Beyond medicinal applications, Yew Bio-Pharm cultivates and markets various forms of yew trees, from young seedlings and mature specimens to ornamental potted miniatures. It also leverages yew tree timber for the creation and sale of furniture and handcrafted items. Its diverse product portfolio further includes a range of agricultural goods such as yew-based candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps. Additionally, it sells wood ear mushrooms. The group also extends its reach into the cosmetics market, engaging in their marketing and distribution. Established in 2007, the company maintains its headquarters in El Monte, California.
Share Price
$0.0002
Last synced: 2023-11-09
Market Cap
$10.40K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Yew Bio-Pharm Group, Inc. (YEWB)
Revenue for Yew Bio-Pharm Group, Inc. (YEWB)
Revenue in Aug 2026 TTM: 0
According to Yew Bio-Pharm Group, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Yew Bio-Pharm Group, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$82.10B -
US
$19.99B -
CN
$91.82B -
US
$55.69B -
US
- -
SG